Sign up
Log in
DNA X FY25 net loss widens to $20.7 million; operating loss grows to $5.4 million
Share
Listen to the news
DNA X FY25 net loss widens to $20.7 million; operating loss grows to $5.4 million
  • DNA X posted 2025 net loss of $20.7 million.
  • Continuing-operations net loss widened to $8 million from $2.9 million, while revenue showed no revenue.
  • General and administrative expense climbed to $5.4 million from $3.1 million.
  • Completed acquisition of DNA X cryptocurrency trading platform in December 2025; closed sale of mobile device assets to NEXA on Jan. 23, 2026 for $15 million, including $13.5 million paid at close.
  • Outlook calls for growth in revenue, gross margin, profitability as platform exits monitoring and testing phase and begins marketing to public.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202604142134NEWSFILECNPR____20260414_292277_1) on April 15, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.